Apoptotic and anti-angiogenic effects of Pulsatilla koreana extract on hepatocellular carcinoma

International Journal of Oncology

Volumn 40, Issue 2, 2012, Pages 452-460

  Hong, Sang Won ^a   Jung, Kyung Hee ^a   Lee, Hee Seung ^a   Choi, Myung Joo ^a   Zheng, Hong Mei ^a   Son, Mi Kwon ^a   Lee, Guang Yong ^a   Hong, Soon Sun ^a  

^a Inha University School of Medicine   (South Korea)

Author keywords

Angiogenesis; Apoptosis; Cancer; Hepatocellular carcinoma; Pulsatilla koreana extract

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ANTINEOPLASTIC AGENT; CASPASE 3; CD31 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; MATRIGEL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT EXTRACT; PULSATILLA KOREANA EXTRACT; SORAFENIB; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; CARCINOMA CELL; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MEDICINAL PLANT; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PULSATILLA KOREANA; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; PLANT EXTRACTS; PLANT ROOTS; PULSATILLA; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84862972561     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1204     Document Type: Article

References (24)

1. Gomaa AI, Khan SA, Toledano MB, Waked I and Taylor-Robinson SD: Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 14: 4300-4308, 2008.
2. Chrisey L, Rossi J and Sarver N: Meeting Report. Ribozymes: progress and prospects of catalytic RNA as therapeutic agents. Antisense Res Dev 1: 57-63, 1991.
3. El-Serag HB, Marrero JA, Rudolph L and Reddy KR: Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134: 1752-1763, 2008. (Pubitemid 351615415)
4. Naithani R, Huma LC, Moriarty RM, McCormick DL and Mehta RG: Comprehensive review of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials. Curr Med Chem 15: 1044-1071, 2008. (Pubitemid 352005717)
5. Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768-780, 2003.
6. Velmurugan B, Singh RP, Agarwal R and Agarwal C: Dietary-feeding of grape seed extract prevents azoxymethane-induced colonic aberrant crypt foci formation in fischer 344 rats. Mol Carcinog 49: 641-652, 2010.
7. Jiang XY, Qian LP, Zheng XJ, Xia YY, Jiang YB and Sun da Y: Interventional effect of Ginkgo biloba extract on the progression of gastric precancerous lesions in rats. J Dig Dis 10: 293-299, 2009.
8. Gutierrez-Orozco F, Stephens BR, Neilson AP, Green R, Ferruzzi MG and Bomser JA: Green and black tea inhibit cytokine-induced IL-8 production and secretion in AGS gastric cancer cells via inhibition of NF-kappaB activity. Planta Med 76: 1659-1665, 2010.
9. Bang KH: The medicinal plant of Korea. Kyo-Hak Press, p139, 1999.
10. Cho SC, Sultan MZ and Moon SS: Anti-acne activities of pulsaquinone, hydropulsaquinone, and structurally related 1, 4-quinone derivatives. Arch Pharm Res 32: 489-494, 2009.
11. Martin ML, San Roman L and Dominguez A: In vitro activity of protoanemonin, an antifungal agent. Planta Med 56: 66-69, 1990. (Pubitemid 20124690)
12. Bang SC, Lee JH, Song GY, Kim DH, Yoon MY and Ahn BZ: Antitumor activity of Pulsatilla koreana saponins and their structure-activity relationship. Chem Pharm Bull (Tokyo) 53: 1451-1454, 2005.
13. Kim Y, Kim SB, You YJ and Ahn BZ: Deoxypodophyllotoxin; the cytotoxic and antiangiogenic component from Pulsatilla koreana. Planta Med 68: 271-274, 2002. (Pubitemid 34271000)
14. Zhang T, Sun HC, Zhou HY, Luo JT, Zhang BL, Wang P, Wang L, Qin LX, Ren N, Ye SL, Li Q and Tang ZY: Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells. Cancer Lett 290: 204-210, 2010.
15. Kuang DM, Zhao Q, Wu Y, Peng C, Wang J, Xu Z, Yin XY and Zheng L: Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol 54: 948-955, 2011.
16. Cragg GM, Newman DJ and Yang SS: Natural product extracts of plant and marine origin having antileukemia potential. The NCI experience. J Nat Prod 69: 488-498, 2006.
17. O'Connor L, Huang DC, O'Reilly LA and Strasser A: Apoptosis and cell division. Curr Opin Cell Biol 12: 257-263, 2000. (Pubitemid 30142575)
18. Yuan J and Horvitz HR: A first insight into the molecular mechanisms of apoptosis. Cell 116 (Suppl. 2): S53-S59, 2004.
19. Wu XZ: New strategy of antiangiogenic therapy for hepatocellular carcinoma. Neoplasma 55: 472-481, 2008.
20. Bolat F, Haberal N, Tunali N, Aslan E, Bal N and Tuncer I: Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor 1 alpha (HIF-1alpha), and transforming growth factors beta1 (TGFbeta1) and beta3 (TGFbeta3) in gestational trophoblastic disease. Pathol Res Pract 206: 19-23, 2010.
21. Nanko N, Tanikawa M, Mase M, Fujita M, Tateyama H, Miyati T and Yamada K: Involvement of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in the mechanism of development of chronic subdural hematoma. Neurol Med Chir (Tokyo) 49: 379-385, 2009.
22. Sartippour MR, Pietras R, Marquez-Garban DC, Chen HW, Heber D, Henning SM, Sartippour G, Zhang L, Lu M, Weinberg O, Rao JY and Brooks MN: The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis 27: 2424-2433, 2006. (Pubitemid 44884099)
23. DeFeudis FV, Papadopoulos V and Drieu K: Ginkgo biloba extracts and cancer: a research area in its infancy. Fundam Clin Pharmacol 17: 405-417, 2003. (Pubitemid 36920641)
24. Llovet J, Ricci S and Mazzaferro V: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359: 378-390, 2008.